Ligand validation:5F4S

13P: 1,3-DIHYDROXYACETONEPHOSPHATE

13P is a Ligand Of Interest in 5F4S designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5F4S_13P_B_401	91%	35%	0.076	0.961	0.86	1.7	-	4	0	0	100%	0.756
5F4S_13P_A_3002	84%	68%	0.1	0.961	0.55	0.67	-	-	1	0	100%	0.261
3MHG_13P_A_3001	99%	28%	0.047	0.98	2.08	0.85	2	-	0	0	100%	0.9
5F4W_13P_A_3003	80%	22%	0.09	0.955	2.16	1.13	3	1	0	0	90%	0.324
5F2G_13P_B_401	54%	20%	0.119	0.881	0.64	2.66	-	4	1	0	100%	0.639
2QJI_13P_M_501	100%	27%	0.031	0.991	1.54	1.38	1	2	2	0	100%	0.9
2R4J_13P_B_816	100%	1%	0.043	0.988	4.34	3.7	6	4	3	0	100%	1
5KTN_13P_A_402	99%	21%	0.052	0.991	2.39	0.95	1	-	0	0	100%	1
3DFS_13P_D_3004	97%	56%	0.066	0.983	0.72	0.99	-	1	1	0	100%	0.9
3T2C_13P_A_411	96%	24%	0.059	0.987	1.09	1.98	-	4	5	0	90%	0.54

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.